Home › Funds › Parkman Healthcare Partners LLC › INDV
Parkman Healthcare Partners LLC position in INDV
INDIVIOR PHARMACEUTICALS INC · Health Care
Parkman Healthcare Partners LLC reported holding 521,580 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$18.7M, representing 1.69% of its reported portfolio and ranking #17 among its reported holdings. Parkman Healthcare Partners LLC has disclosed INDV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's INDV position evolved
Parkman Healthcare Partners LLC first disclosed a stake in INDV in Q2 2026 at 364,269 shares (US$14.9M). The position peaked in Q3 2026 at 521,580 shares, worth US$18.7M. Across 2 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 521,580 shares valued at US$18.7M — an increase of 157,311 shares quarter over quarter.. Notable position changes include a 43% increase in Q3 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 364.27K | $14.95M | New |
| Q3 2026 | 521.58K | $18.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INDV and 13F data
INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$173.9M), Two Seas Capital LP (US$131.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INDV
- OAKTREE CAPITAL MANAGEMENT LP 6.13M sh · $251.40M · Q2 2026
- Madison Avenue Partners, LP 4.85M sh · $173.94M · Q3 2026
- Two Seas Capital LP 3.67M sh · $131.61M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M sh · $67.65M · Q2 2026
- Jones Hill Capital LP 1.53M sh · $54.73M · Q3 2026
- Newtyn Management, LLC 1.31M sh · $53.58M · Q2 2026
- Soleus Capital Management, L.P. 1.06M sh · $43.66M · Q2 2026
- GENDELL JEFFREY L 1.15M sh · $41.10M · Q3 2026
- MANGROVE PARTNERS IM, LLC 1.13M sh · $40.68M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 945.55K sh · $33.90M · Q3 2026
- Westchester Capital Management, LLC 775.86K sh · $27.81M · Q3 2026
- PFM Health Sciences, LP 741.86K sh · $26.60M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held INDV?
Parkman Healthcare Partners LLC has disclosed INDV holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Parkman Healthcare Partners LLC's current position in INDV?
As of Q3 2026, Parkman Healthcare Partners LLC holds 521.58K shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $18.70M, representing 1.69% of its reported portfolio and ranking #17.
Has Parkman Healthcare Partners LLC been buying or selling INDV?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC increased its position in INDV. The position peaked in Q3 2026 at 521.58K shares.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, Two Seas Capital LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.